Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Tue, 25 Jun 2019 09:15:39 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190624132038_14122128 Mon, 24 Jun 2019 13:20:38 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190624132038_14122128 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190621143607_14120429 Fri, 21 Jun 2019 14:36:07 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190621143607_14120429 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190620133656_14118644 Thu, 20 Jun 2019 13:36:56 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190620133656_14118644 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190620130031_14118618 Thu, 20 Jun 2019 13:00:31 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190620130031_14118618 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190619091624_14116524 Wed, 19 Jun 2019 09:16:24 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190619091624_14116524 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190618163717_14115594 Tue, 18 Jun 2019 16:37:17 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190618163717_14115594 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190618133740_14115381 Tue, 18 Jun 2019 13:37:40 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190618133740_14115381 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190618122820_14115307 Tue, 18 Jun 2019 12:28:20 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190618122820_14115307 <![CDATA[RNS press release - Collaboration with Genomics England ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190528070011_14088091 Tue, 28 May 2019 07:00:11 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190528070011_14088091 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190520164613_14080711 Mon, 20 May 2019 16:46:13 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190520164613_14080711 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190514150007_14073677 Tue, 14 May 2019 15:00:07 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190514150007_14073677 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190430070019_14056386 Tue, 30 Apr 2019 07:00:19 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190430070019_14056386 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190426143558_14054065 Fri, 26 Apr 2019 14:35:58 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190426143558_14054065 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190425165536_14052511 Thu, 25 Apr 2019 16:55:36 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190425165536_14052511 <![CDATA[RNS press release - Silence Therapeutics Announces Board Changes ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190425070008_14051042 Thu, 25 Apr 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190425070008_14051042 <![CDATA[RNS press release - Appointment of Chief Financial Officer ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190418070008_14045569 Thu, 18 Apr 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190418070008_14045569 <![CDATA[RNS press release - Silence Therapeutics Publication of Annual Report ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190418070003_14045484 Thu, 18 Apr 2019 07:00:03 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190418070003_14045484 <![CDATA[RNS press release - Silence Therapeutics Announces Board Change ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190416110002_14043001 Tue, 16 Apr 2019 11:00:02 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190416110002_14043001 <![CDATA[RNS press release - Silence Therapeutics appoints Head of R&D and CMO ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190416070015_14042111 Tue, 16 Apr 2019 07:00:15 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190416070015_14042111 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190404090932_14028812 Thu, 04 Apr 2019 09:09:32 +0100 https://www.proactiveinvestors.co.uk/LON:SLN/Silence-Therapeutics-PLC/rns/LSE20190404090932_14028812